Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Jan 25 | DRMA Dermata Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.38 | 5,000 | 6.90 k | 5,000 |
2 Jan 25 | SPRY ARS Pharmaceuticals | Stock option Common Stock | Grant | Acquire A | No | No | 10.71 | 176,700 | 1.89 mm | 176,700 |
6 Dec 24 | NKGN NKGen Biotech, Inc. Common Stock | Stock Option Common Stock | Grant | Acquire A | No | No | 0.438 | 500,000 | 219.00 k | 500,000 |
6 Dec 24 | NKGN NKGen Biotech, Inc. Common Stock | Stock Option Common Stock | Grant | Acquire A | No | No | 1.62 | 300,000 | 486.00 k | 300,000 |
16 Oct 24 | SPRY ARS Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 16 | 12,500 | 200.00 k | 4,949 |
16 Oct 24 | SPRY ARS Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 1.5 | 12,500 | 18.75 k | 17,449 |
16 Oct 24 | SPRY ARS Pharmaceuticals | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.5 | 12,500 | 18.75 k | 802,330 |
20 Aug 24 | SPRY ARS Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 16 | 12,500 | 200.00 k | 13,199 |
20 Aug 24 | SPRY ARS Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 1.5 | 12,500 | 18.75 k | 25,699 |
20 Aug 24 | SPRY ARS Pharmaceuticals | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.5 | 12,500 | 18.75 k | 814,830 |